High incidence of serious infections requiring hospitalisation in human T-cell leukaemia virus type 1-positive rheumatoid arthritis: A case-controlled observational study

• Published in: Modern rheumatology 2022-08, Vol.32 (5), p.866-874
• Main Authors: Hashiba, Yayoi, Umekita, Kunihiko, Kimura, Masatoshi, Iwao, Chihiro, Iwao, Kosho, Kariya, Yumi, Kubo, Kazuyoshi, Miyauchi, Shunichi, Kudou, Risa, Rikitake, Yuki, Kawaguchi, Takeshi, Matsuda, Motohiro, Takajo, Ichiro, Inoue, Eisuke, Hidaka, Toshihiko, Okayama, Akihiko
• Format: Article
• Language: English
• ISSN: 1439-7595; 1439-7609
• DOI: 10.1093/mr/roab077

We aimed to assess the clinical features of human T-cell leukaemia virus type 1 (HTLV-1)-positive rheumatoid arthritis (RA) patients. Furthermore, we investigated the impact of HTLV-1 infection on incidences of serious infections requiring hospitalisation (SIH) and malignancies. A total of 150 sex- and age-matched HTLV-1-negative and 50 HTLV-1-positive RA patients were enrolled from the HTLV-1 RA Miyazaki Cohort Study. Clinical and laboratory data were collected from this cohort database. The incidence rate (IR) for SIH and malignancies from 2015 to 2020 was analysed. The median age and female ratio in the study population were 70 years old and 80%, respectively. Although no differences were found in inflammatory marker values between the two groups, the patient global assessment and Health Assessment Questionnaire scores were higher in HTLV-1-positive RA patients. In HTLV-1-negative RA patients, the IR for SIH was 6.37/100 person-years (PY) and 1.32/100 PY for malignancies. In HTLV-1-positive RA patients, SIH occurred in 11.1/100 PY and malignancies in 2.46/100 PY. The crude IR ratio comparing SIH between two groups was 1.74 (95% confidence interval, 1.04-2.84), which was a significant increase. HTLV-1-positive RA patients may worsen RA symptoms. HTLV-1 may be a risk factor for SIH.